Evidence map›Paper›PMID 26992419›Full record

ArticleEuropean heart journal. Cardiovascular Imaging2016

Multicentre multi-device hybrid imaging study of coronary artery disease: results from the EValuation of INtegrated Cardiac Imaging for the Detection and Characterization of Ischaemic Heart Disease (EVINCI) hybrid imaging population.

Riccardo Liga, Jan Vontobel, Daniele Rovai, Martina Marinelli, Chiara Caselli, Mikko Pietila, Anna Teresinska, Santiago Aguadé-Bruix, Maria Nazarena Pizzi, Giancarlo Todiere and 45 more

Registry-linked trialOpen access · bronzeAbstract readEvaluation StudyMulticenter Study
In one paragraph

Article in European heart journal. Cardiovascular Imaging, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02968771 (Metabolomic Profile of Patients Undergoing Myocardial Perfusion SPECT), which is not on this map. Cited by 44 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 3 pooled it
15.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02968771 unknown statusnot on this map

Metabolomic Profile of Patients Undergoing Myocardial Perfusion SPECT

TypeobservationalSponsorHospital Universitari Vall d'Hebron Research InstituteRan2016 to 2022Enrolled500ConditionsIschemic Heart DiseaseArmsNon intervention
3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 3 syntheses or guidelines pooled it, 112 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Recent Progress in Myocardial Perfusion Imaging Techniques.Nuclear medicine and molecular imaging · 2024
    Review
  9. Review
  10. Article
  11. Coronary physiology in the cath lab: is "virtual FFR" ready for the prime time?Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023
    Article
  12. Risk stratification of patients with INOCA: is perfusion PET imaging the game winner?Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023
    Article
  13. Prognostic impact of patients' management based on anatomic/functional phenotype: a study in patients with chronic coronary syndromes.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Dynamic ultrafast CZT imaging: Time for a paradigm change in myocardial perfusion imaging.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Article
  18. Clinical significance of corrected relative flow reserve derived fromJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Article
  19. MPI in the era of CZT cameras: Absolute numbers are still better than relative figures.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

55 authors at 20 institutions in 10 countries.

Riccardo LigaCardio-Thoracic and Vascular Department, University Hospital of Pisa, Pisa, Italy Department of Nuclear Medicine, Cardiac Imaging, University Hospital Zurich, Ramistrasse 100, CH-8091 Zurich, Switzerland.
Jan VontobelDepartment of Nuclear Medicine, Cardiac Imaging, University Hospital Zurich, Ramistrasse 100, CH-8091 Zurich, Switzerland.
Daniele RovaiInstitute of Clinical Physiology, CNR, Pisa, Italy.
Martina MarinelliInstitute of Clinical Physiology, CNR, Pisa, Italy.
Chiara CaselliInstitute of Clinical Physiology, CNR, Pisa, Italy.
Mikko PietilaHeart Center and Turku PET Center, University of Turku, Turku University Hospital, Turku, Finland.
Anna TeresinskaDepartment of Nuclear Medicine, Institute of Cardiology, Warsaw, Poland.
Santiago Aguadé-BruixDepartment of Nuclear Medicine, University Hospital Val d'Hebron, Institut Catala de la Salut, Barcelona, Spain.
Maria Nazarena PizziDepartment of Nuclear Medicine, University Hospital Val d'Hebron, Institut Catala de la Salut, Barcelona, Spain.
Giancarlo TodiereCardiothoracic Department, Fondazione Toscana G. Monasterio, Pisa, Italy.
Alessia GimelliImaging Department, Fondazione Toscana G. Monasterio, Pisa, Italy.
Dante ChiappinoImaging Department, Fondazione Toscana G. Monasterio, Pisa, Italy.
Paolo MarracciniInstitute of Clinical Physiology, CNR, Pisa, Italy.
Stephen SchroederDepartment of Cardiology, Alb-Fils-Kliniken, Göppingen, Germany.
Tanja DroschDepartment of Cardiology, Alb-Fils-Kliniken, Göppingen, Germany.
Rosa PoddigheEmergency Department, Cardiology, Ospedale della Versilia, Lido di Camaiore, Italy.
Giancarlo CasoloEmergency Department, Cardiology, Ospedale della Versilia, Lido di Camaiore, Italy.
Constantinos AnagnostopoulosCenter for Experimental Surgery, Clinical and Translational Research, Biomedical Research Foundation, Academy of Athens, Athens, Greece Centre for Advanced Cardiovascular Imaging, National Institute for Health Research Cardiovascular Biomedical Research Unit at Barts, William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University of London, London, UK.
Francesca PuglieseCentre for Advanced Cardiovascular Imaging, National Institute for Health Research Cardiovascular Biomedical Research Unit at Barts, William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University of London, London, UK.
Francois RouzetDepartment of Nuclear Medicine, Bichat University Hospital, Département Hospitalo-Universitaire FIRE, Assistance Publique-Hôpitaux de Paris, University Paris Diderot, Paris, France.
Dominique Le GuludecDepartment of Nuclear Medicine, Bichat University Hospital, Département Hospitalo-Universitaire FIRE, Assistance Publique-Hôpitaux de Paris, University Paris Diderot, Paris, France.
Francesco CappelliCardiothoracic and Vascular Department, Azienda Ospedaliera Universitaria Careggi, Florence, Italy.
Serafina ValenteCardiothoracic and Vascular Department, Azienda Ospedaliera Universitaria Careggi, Florence, Italy.
Gian Franco GensiniCardiothoracic and Vascular Department, Azienda Ospedaliera Universitaria Careggi, Florence, Italy Don Carlo Gnocchi Foundation, IRCCS, Florence, Italy.
Camilla ZawaidehDepartment of Health Science and Internal Medicine, IRCCS Hospital San Martino, National Institute for Cancer Research and University of Genoa, Genoa, Italy.
Selene CapitanioDepartment of Health Science and Internal Medicine, IRCCS Hospital San Martino, National Institute for Cancer Research and University of Genoa, Genoa, Italy.
Gianmario SambucetiDepartment of Health Science and Internal Medicine, IRCCS Hospital San Martino, National Institute for Cancer Research and University of Genoa, Genoa, Italy.
Fabio MarsicoDepartment of Advanced Biomedical Sciences, Federico II University, Naples, Italy.
Pasquale Perrone FilardiDepartment of Advanced Biomedical Sciences, Federico II University, Naples, Italy.
Covadonga Fernández-GolfínDepartment of Cardiology, University Hospital Ramón y Cajal, Madrid, Spain.
Luis M RincónDepartment of Cardiology, University Hospital Ramón y Cajal, Madrid, Spain.
Frank P GranerDepartment of Nuclear Medicine, Klinikum Rechts der Isar der Technischen Universität München, Muenchen, Germany.
Michiel A de GraafDepartment of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.
Julia StehliDepartment of Nuclear Medicine, Cardiac Imaging, University Hospital Zurich, Ramistrasse 100, CH-8091 Zurich, Switzerland.
Eliana ReyesBiomedical Research Unit, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College London, London, UK.
Sandy NkomoBiomedical Research Unit, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College London, London, UK.
Maija MäkiHeart Center and Turku PET Center, University of Turku, Turku University Hospital, Turku, Finland.
Valentina LorenzoniInstitute of Management, Scuola Superiore Sant'Anna, Pisa, Italy.
Giuseppe TurchettiInstitute of Management, Scuola Superiore Sant'Anna, Pisa, Italy.
Clara CarpeggianiInstitute of Clinical Physiology, CNR, Pisa, Italy.
Stefano PuzzuoliTechnology Department, Fondazione Toscana G. Monasterio, Pisa, Italy.
Maurizio MangioneTechnology Department, Fondazione Toscana G. Monasterio, Pisa, Italy.
Paolo MarcheschiTechnology Department, Fondazione Toscana G. Monasterio, Pisa, Italy.
Daniela GiannessiInstitute of Clinical Physiology, CNR, Pisa, Italy.
Stephan NekollaDepartment of Nuclear Medicine, Klinikum Rechts der Isar der Technischen Universität München, Muenchen, Germany.
Massimo LombardiImaging Department, Fondazione Toscana G. Monasterio, Pisa, Italy.
Rosa SicariInstitute of Clinical Physiology, CNR, Pisa, Italy.
Arthur J H A ScholteDepartment of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.
José L ZamoranoDepartment of Cardiology, University Hospital Ramón y Cajal, Madrid, Spain.
S Richard UnderwoodBiomedical Research Unit, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College London, London, UK.
Juhani KnuutiHeart Center and Turku PET Center, University of Turku, Turku University Hospital, Turku, Finland.
Philipp A KaufmannDepartment of Nuclear Medicine, Cardiac Imaging, University Hospital Zurich, Ramistrasse 100, CH-8091 Zurich, Switzerland.
Danilo NegliaInstitute of Clinical Physiology, CNR, Pisa, Italy Cardiothoracic Department, Fondazione Toscana G. Monasterio, Pisa, Italy.
Oliver GaemperliDepartment of Nuclear Medicine, Cardiac Imaging, University Hospital Zurich, Ramistrasse 100, CH-8091 Zurich, Switzerland oliver.gaemperli@usz.ch.
EVINCI Study Investigators
Fondazione Toscana Gabriele Monasterio · ITIstituto di Fisiologia Clinica · ITUniversity Hospital of Zurich · CHHospital Universitario Ramón y Cajal · ESRoyal Brompton Hospital · GBUniversity of Genoa · ITAlb Fils Kliniken · DEAzienda Ospedaliero-Universitaria Careggi · ITFederico II University Hospital · ITInstitut Català de la Salut · ESKlinikum rechts der Isar · DELeiden University Medical Center · NLOspedale Versilia · ITScuola Superiore Sant'Anna · ITTurku University Hospital · FIDélégation Paris 7 · FRDon Carlo Gnocchi Foundation · ITInstitute of Cardiology · PLNational Institute for Health Research · GBUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsHybrid imaging provides a non-invasive assessment of coronary anatomy and myocardial perfusion. We sought to evaluate the added clinical value of hybrid imaging in a multi-centre multi-vendor setting. METHODS AND

resultsFourteen centres enrolled 252 patients with stable angina and intermediate (20-90%) pre-test likelihood of coronary artery disease (CAD) who underwent myocardial perfusion scintigraphy (MPS), CT coronary angiography (CTCA), and quantitative coronary angiography (QCA) with fractional flow reserve (FFR). Hybrid MPS/CTCA images were obtained by 3D image fusion. Blinded core-lab analyses were performed for CTCA, MPS, QCA and hybrid datasets. Hemodynamically significant CAD was ruled-in non-invasively in the presence of a matched finding (myocardial perfusion defect co-localized with stenosed coronary artery) and ruled-out with normal findings (both CTCA and MPS normal). Overall prevalence of significant CAD on QCA (>70% stenosis or 30-70% with FFR≤0.80) was 37%. Of 1004 pathological myocardial segments on MPS, 246 (25%) were reclassified from their standard coronary distribution to another territory by hybrid imaging. In this respect, in 45/252 (18%) patients, hybrid imaging reassigned an entire perfusion defect to another coronary territory, changing the final diagnosis in 42% of the cases. Hybrid imaging allowed non-invasive CAD rule-out in 41%, and rule-in in 24% of patients, with a negative and positive predictive value of 88% and 87%, respectively.

conclusionIn patients at intermediate risk of CAD, hybrid imaging allows non-invasive co-localization of myocardial perfusion defects and subtending coronary arteries, impacting clinical decision-making in almost one every five subjects.

Indexed as

Image Interpretation, Computer-AssistedAgedCohort StudiesComputed Tomography AngiographyCoronary AngiographyCoronary Artery DiseaseEuropeFemaleFractional Flow Reserve, MyocardialHumansInternationalityMaleMiddle AgedMultimodal ImagingMyocardial IschemiaMyocardial Perfusion ImagingCoronary artery diseaseCT coronary angiographyHybrid imagingMyocardial perfusion scintigraphy

Identifiers

PMID26992419
PMCPMC5841878
OpenAlexW2307170589

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.